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Primary tumors have a high likelihood of developing metastases
in the liver and early detection of these metastases is crucial for
patient outcome. We propose a method based on convolutional
neural networks (CNN) to detect liver metastases. First, the
liver was automatically segmented using the six phases of ab-
dominal dynamic contrast enhanced (DCE) MR images. Next,
DCE-MR and diffusion weighted (DW) MR images are used for
metastases detection within the liver mask. The liver segmenta-
tions have a median Dice similarity coefficient of 0.95 compared
with manual annotations. The metastases detection method has
a sensitivity of 99.8% with a median of 2 false positives per im-
age. The combination of the two MR sequences in a dual path-
way network is proven valuable for the detection of liver metas-
tases. In conclusion, a high quality liver segmentation can be
obtained in which we can successfully detect liver metastases.
Dynamic contrast enhanced MRI, diffusion weighted MRI, liver, segmentation,
detection, deep learning
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Introduction
Primary tumors, such as neuroendocrine and colorectal tu-
mors, have a high likelihood of developing metastases in
the liver.1,2 Early detection of (new) liver metastases is cru-
cial since it improves patient outcome.3-5 To follow disease
progress, radiologists check for tumor growth and new (liver)
metastases in computed tomography (CT) or magnetic reso-
nance (MR) images.
While CT has long been the modality of choice in detecting
and monitoring liver tumors, MRI has gained interest thanks
to a better lesion-to-liver contrast and because it does not use
ionizing radiation.6,7 Dynamic contrast-enhanced (DCE) MR
images have a high sensitivity and specificity for visual de-
tection of liver metastases. Moreover, the combination of
DCE-MR and diffusion weighted (DW) MR images turned
out to be even more effective in the visual detection of liver
metastases and visual censoring of mimics.8,9,10
The automatic detection and characterization of liver metas-
tases remains a challenging task, given the heterogeneous ap-
pearance of liver metastases on MR images.11,12 Radiologists
have a liver lesion detection rate between 87-95%, when us-
ing both DCE-MR and DW-MR images.7,8,9 Automatic liver
metastases detection could aid radiologists in finding metas-
tases more efficiently and effectively.
The liver metastases detection method we propose is a two-
step method: a liver segmentation step followed by a lesion
detection step within the segmented liver. Most liver seg-
mentation methods published have been developed for CT,
with best results by convolutional neural network (CNN)
based methods.13,14 Fewer methods have been developed
for segmentation of the liver in MR images. Those known
are primarily based on watershed15,16, active contouring17,
atlases18, or shape models19.
For automatic detection of liver lesions several methods have
been proposed, all based on CT images.14, 20-23 MR data was
employed by a few methods to detect hepatocellular carcino-
mas (either DCE-MRI24 or DW-MRI25), but not for metas-
tases.
Our aim is to develop and evaluate a two-step liver metas-
tases detection method for MR images, based on fully convo-
lutional neural networks (FCN). In the first step, a liver seg-
mentation method utilizing the dynamic nature of the DCE-
MR images is presented, based on previous work26. This is
followed by a method for the detection of metastases within
the liver region using both DCE-MR and DW-MR images as
input.
Data
The study comprises MR data of 121 patients with a clin-
ical focus on the liver from the University Medical Center
Utrecht, the Netherlands, acquired between February 2015
and February 2018. The UMCU Medical Ethical Commit-
tee has reviewed this study and informed consent was waived
due to its retrospective nature.
All patients underwent a clinical MR examination, includ-
ing DCE-MR series and DW-MRI. The DCE-MR series was
acquired in six breath holds with one to five 3D images per
breath hold, with the following parameters: TE: 2.143 ms;
TR: 4.524 ms; flip angle: 10 degrees. After acquiring the
first image, gadobutrol (0.1 ml/kg Gadovist of 1.0 mmol/ml
at 1 ml/s) was administered at once, followed by 25 ml saline
solution at 1 ml/s. In total, 16 3D images per patient were ac-
quired with 100 slices and matrix sizes of 256 × 256. Voxel
size was 1.543 mm × 1.543 mm × 2 mm.
The DW-MR images were acquired with three b-values: 10,
150, and 1000 s/mm2, using a protocol with the following
parameters: TE: 70 ms; TR: 1.660 ms; flip angle: 90 degrees.
Each b-value image was acquired with 42 slices and matrix
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sizes of 256 × 256. Voxel size was 1.758 mm × 1.758 mm
× 5 mm.
Pre-processing.
DCE-MR. All DCE-MR data sets were corrected for motion
using a groupwise registration.27 The groupwise registration
method registers all images simultaneously to a common
space by minimizing a cost function based on principle com-
ponent analysis and applying a B-spline transformation. The
registration is applied on four resolutions with 500 iterations
each. After registration, a zero-mean-unit-variance rescaling
was applied to all intensity values between the 0th and 99.8th
percentile of the intensity histogram of DCE-MR series. The
99.8th percentile intensity was assumed to correspond to the
contrast agent peak in the aorta.
The images were combined per phase by averaging the fourth
dimension. The series started with the pre-contrast im-
age, followed by the other phases: the early arterial phase,
the late arterial phase, the hepatic/portal-venous phase, the
late portal-venous/equilibrium phase and the late equilibrium
phase. The six phases were used as input images for the FCN.
DW-MR. The DW-MR images were nonlinearly registered to
the DCE-MR space using elastix, a toolbox for linear and
non-linear registration of medical images.28 The fixed im-
age was the mean DCE-MR, obtained by averaging over the
six phases. First a rigid transformation was applied on two
resolutions with 2000 iterations each, followed by a b-spline
transformation on one resolution with 1000 iterations and a
grid spacing of 60×60×40 mm. Normalized mutual infor-
mation was used as metric. A mask was used to focus the
registration on the liver. The mask was obtained from the
automatic liver segmentation, morphologically dilated with a
10×10×10 structuring element. A substantial dilation was
chosen to make sure the boundary of the liver is included.
Ten out of the 121 MRI examinations were excluded from the
study because of a failed registration of the DW-MRI on the
DCE-MR series. The exclusion was based on visual evalua-
tion.
The intensities of the registered DW-MR data set were
also normalized with a zero-mean-unit-variance rescaling be-
tween the 0th and 99.8th percentile of the intensity histogram
of the DW-MRI.
Annotations. The liver was annotated in 55 DCE-MR se-
ries, of which only 16 series contained metastases that were
segmented. Additionally, we included another 56 DCE-MR
series in which the metastases were segmented, resulting in a
total of 72 DCE-MR series with annotated metastases.
Liver segmentation. Fifty-five dynamic contrast enhanced
MR series were used for liver segmentation. The data sets
were randomly divided in thirty-three data sets for training,
three for validation, and nineteen data sets for testing. The
validation set was used for tuning the hyperparameters and
the evaluation of the CNN model during method develop-
ment. The test set was used to evaluate the final CNN model
in an independent manner.
The liver was manually contoured by two observers, see Fig.
3 for segmentation examples. The first observer annotated the
training, validation, and test sets. The annotation of the test
set is indicated as O1.1. The first observer repeated the anno-
tations of the test set at least one week later (O1.2). The sec-
ond observer annotated the test set once (O2). This was done
to estimate the inter- and intra-observer agreement. A radi-
ologist with more than ten years of experience in liver MR
analysis verified all manual annotations and provided correc-
tions where needed. Liver lesions were included in the an-
notation and this network was therefore trained to recognize
liver lesions as liver tissue. The first set of annotations of the
first observer was used as reference in the experiments.
Liver metastases detection. Seventy-two MR data sets were
used for the liver metastases detection. The data set in-
cluded mainly colorectal metastases, neuroendocrine metas-
tases, and some other metastasis types (i.e. other gastroin-
testinal metastases and breast metastases). The data sets were
randomly divided in fifty-five data sets for training (n=50)
and validation (n=5), and seventeen data sets for testing. The
training and validation sets contained 334 metastases in total,
with on average 6 metastases per liver (range: 1 - 31 metas-
tases). The test set contained 86 metastases in total, with on
average 5 metastases per liver (range: 1 - 32 metastases).
The metastases were manually annotated on the DCE-MR
images by a radiologist in training and were verified by a
radiologist with more than ten years of experience.
Methods
Liver segmentation. An FCN29 with dilated convolutions
was implemented, for which the six phases of the DCE-MR
images were the channels of the input image. The dilated
FCN consisted of 9 convolutional layers in total. The first 7
layers had a 3×3 convolution and 32 kernels. The dilation
rates ranged from 1 to 16. The final two layers had a 1×1
convolution. ReLU activation and batch normalization were
used in all the convolutional layers, except for the final layer
which had a softmax activation. A dropout layer was applied
between the 8th and the 9th layer with a dropout rate of 0.5.
This network had a receptive field of 67×67 pixels. Figure
1 gives an overview of the network architecture. In our pre-
vious work on liver segmentation26, we also considered the
popular U-net architecture. However, this architecture had a
slightly worse performance than the herein used FCN archi-
tecture.
The loss was calculated by a similarity metric based on the
Dice similarity coefficient: (2 ∗X ∩Y + s)/(X2+Y 2+ s),
where X is the predicted segmentation, Y is the ground truth
mask, and s is a small number to prevent dividing by zero
(set to 1e-5).30 Glorot uniform31 was used as initializer and
Adam as optimizer with a learning rate of 0.001. The network
was trained for 100,000 iterations, with six images per mini
batch. The total number of 2D slices for training was 3300
slices. No data augmentation was applied.
The data was processed by the network per 2D slice consist-
ing of 6 channels. For the evaluation of the liver segmen-
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Fig. 1. Network architecture for liver segmentation. The blue blocks represent the
convolutional layers, batch normalization (BN) and ReLU or softmax activation. The
size of the kernel of each convolutional layer is given in the block, followed by the
number of kernels and the dilation rate of the kernel.
Fig. 2. Network architecture for liver metastases detection. The blue blocks repre-
sent the convolutional layers, batch normalization (BN) and ReLU or softmax activa-
tion. The size of the kernel of each convolutional layer is given in the block, followed
by the number of kernels and the dilation rate of the kernel.
tation, the probability output was post-processed to a binary
image. The threshold of 0.5 was applied to the probability
output of the network. After that 3D hole filling was per-
formed, so that all holes caused by liver lesions were filled.
To remove small spurious segmentations, the largest con-
nected component was selected as the final segmentation.
Liver metastases detection. A dual pathway FCN was im-
plemented, for which the input images of one path were the
six DCE-MR phase images and for the other path the three
DW-MR images. The six (or three) 2D images were com-
bined to one input image, with six (or three) channels. Each
pathway had 13 convolutional layers with a 3×3 convolu-
tion and 64 kernels, split in five blocks with different dilation
rates, ranging from 1 to 8. The feature maps at the end of each
block of each pathway were concatenated in the third dimen-
sion, resulting in a feature map with 640 kernels, and were
passed to two convolutional layers with a 1×1 convolution
with 128 and 2 kernels, respectively. This resulted in a recep-
tive field of 123×123 pixels. The individual pathways were
inspired by the P-net architecture.32 Fig. 2 gives an overview
of the network architecture.
In addition, the network was also trained and evaluated as a
single pathway FCN, once with only the DCE-MR images as
input images with six channels, and once with the DCE-MR
and DW-MR images concatenated as input images with nine
channels. In this manner the additional value of the DW-MR
images and the addition of a second pathway in the detec-
tion method can be determined. The single pathway FCN
was identical to the top pathway in Fig. 2. In the concate-
nation layer, the feature maps at the end of each block were
concatenated in the third dimension.
Categorical cross-entropy was used as the loss function.
ReLU activation and batch normalization were used in all the
convolutional layers, except for the final layer which had a
softmax activation. Two dropout layers were applied before
and after the second-to-last layer. The dropout rate was set to
0.2. The classes were weighted based on class frequencies.
He uniform33 was used as initializer and Adam as optimizer
with a learning rate of 0.0001. The network was trained for
10,000 iterations, with 4 images per mini batch. The slices
to train on were limited to the slices containing lesions for a
more balanced data set, resulting in a total number of 1619
2D slices for training and 180 slices for validation.
Twenty-five patches of 128×128 pixels were taken from each
slice for data augmentation. The patches originated from the
liver region and have overlapping areas. Data augmentation
was applied by random rotation of the patches, with rotation
angles of ±45 degrees.
The data of the test set was processed by the network per
2D image slice. The input image slice consisted either of
six channels of the DCE-MR phase images, three channels
of DWI images, or nine channels, depending on the network.
The probability output was masked by the liver segmentation,
which was dilated with a 5×5 structuring element. The dila-
tion of the liver segmentation is a safety measure to ensure
that small failures in the liver segmentation would not lead to
undetected liver metastases.
For the evaluation of the detection, the masked probability
output was post-processed to a binary image. All pixels with
a probability output higher than the threshold of 0.5 were la-
belled as metastasis. Morphological closing with a structur-
ing element of 3×3×3 was applied to fill any holes in the
binary image. The morphological closing was followed by
a morphological opening with a plus-shaped structuring ele-
ment of 3×3, to remove any remaining noise in the detection
results. The resulting binary image was divided into sepa-
rate objects representing individual metastases, using voxel
clustering with 26-neighbourhood connection.
Experiments
Liver segmentation. The performance of the liver segmen-
tation was evaluated based on the Dice similarity coefficient
(DSC), the relative volume difference (RVD), and the mod-
ified Hausdorff distance (HD) at the 95th percentile. The
first annotations of the first observer of the test set (O1.1)
are used to evaluate the automatic segmentation, since these
were made by the same observer in the same session as the
annotations of the training and validation sets.
DSC: (2 ∗X ∩Y )/(X +Y ), where X is the automatic seg-
mentation and Y annotation O1.1.
RVD:(X−Y )/Y ∗100%
HD at 95th percentile: max(h95(X,Y ),h95(Y,X)) , with
h95(X,Y ) =K95
th
(x∈X)min(y∈Y )‖y−x‖. Here, X is the set
of boundary points {x1, .. xN} of the automatic segmentation
result, and Y is the set of boundary points {y1, .. yN} of
annotation O1.1. K95
th
denotes the 95th ranked value in the
set of distances between all boundary points in X and the
closest boundary points in Y .34
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Fig. 3. Three examples of liver and metastases segmentations. From left to
right each column represents a late arterial phase DCE-MR image, the registered
DW-MR image with b-value 150 s/mm², the manually annotated liver (orange) and
metastases (green), and the automatically segmented liver (orange) and metas-
tases (green). The bottom row shows a false positive object in the anterior side of
the liver for the automatic detection, which is a cyst.
These three metrics were computed on the predicted segmen-
tation results. In addition, the three metrics were computed
for the second annotations of the first observer (O1.2) and the
annotations of the second observer (O2) to obtain the intra-
and inter-observer agreement, respectively.
Liver metastases detection. A liver metastasis was con-
sidered detected, and thus a true positive object, when the
manual annotation and the predicted segmentations had an
overlap greater than 0.
For the evaluation of the liver metastases detection, the true
positive rate (TPR) and the number of false positives per case
(FPC) were reported. The TPR was calculated as the number
of true positive objects divided by the total number of true
lesion objects. The FPC was calculated as the number of
objects not overlapping with any true metastasis object. In
addition, the TPR and FPC were given for several thresholds
in a Free-response Receiver Operating Characteristic (FROC)
curve.
The same metrics were applied to the segmentation results of
the single pathway networks.
An expert radiologist verified the results and determined the
underlying physiology of selected false positive objects.
Results
Fig. 3 shows some examples of the late arterial phase of the
DCE-MRI, the DW-MRI with b-value 150 s/mm2, the man-
ually annotated liver and metastases, and the automatic seg-
mentation of the liver with the detection of the liver metas-
tases involving both DCE-MR and DW-MR images in the
dual pathway FCN. It shows good liver and lesion segmen-
tations, with a false positive object in the last row, which is
verified to be a cyst.
Liver segmentation. The median DSC is 0.95 for the au-
tomatic segmentation, 0.94 for the inter-observer agreement,
Fig. 4. Boxplots of the Dice similarity coefficient, relative volume difference (%),
and modified Hausdorff distance (mm).
and 0.96 for the intra-observer agreement. The median RVD
is -1.6% for the automatic segmentation, -3.4% for the inter-
observer agreement, and -1.5% for the intra-observer agree-
ment. The median HD is 5.5 mm for the automatic segmen-
tation, 5.6 mm for the inter-observer agreement, and 3.1 mm
for the intra-observer agreement. The distributions of the
DSC, RVD, and modified HD are given in boxplots in Fig.
4.
In the boxplots, annotations O1.1 are used to evaluate the
automatic liver segmentations. Some variance is present be-
tween the different annotations of the observers and therefore
we also compared the automatic method to all manual an-
notations. The median [interquartile range (IQR)] values of
the DSC, RVD, and modified HD for the automatic segmen-
tation, the inter-observer agreements, and the intra-observer
agreement using the three manual annotations are given in
Table 1. The upper three rows give the same results as the
boxplots and the lower three rows give additional results.
Example results of the automatic liver segmentation are
shown in the last column of Figure 3 and in Figure 8.
Liver metastases detection. Fig. 5 shows the TPR and the
FPC for all subjects. The average TPR for the single pathway
network using only DCE-MRI is 0.645 and for using both
Table 1. Median and interquartile range for the Dice similarity coefficient (DSC),
relative volume difference (RVD), and modified Hausdorff distance (HD) are given.
In each row of the first column, the latter observer is used as the reference. The
upper three rows are the same results as given in Figure 4. The lower three rows
are additional results.
DSC RVD(%) HD (mm)
Automatic
- O1.1 0.95 [0.93–0.96] -1.6 [-3.5–0.8] 5.5 [4.0–8.0]
Inter-observer
O2 - O1.1 0.94 [0.93–0.95] -3.4 [-5.1–0.6] 5.6 [4.3–6.8]
Intra-observer
O1.2 - O1.1 0.96 [0.96–0.97] -1.5 [-1.9– -0.9] 3.1 [2.5–3.1]
Automatic
- O1.2 0.95 [0.93–0.96] -0.1 [-2.8–2.2] 4.9 [3.7–8.0]
Automatic
- O2 0.95 [0.93–0.95] 0.5 [-3.8–5.5] 6.2 [4.9–9.6]
Inter-observer
O2 - O1.2 0.95 [0.94–0.96] -2.5 [-4.0–1.6] 4.4 [3.7–4.8]
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Fig. 5. The true positive rate and the number of false positives per subject for the
single pathway and the dual pathway networks.
Fig. 6. The number of lesions plotted against the size of the lesions. The colored
part represents the detected lesions and the white part the missed lesions at a
threshold of 0.50.
DCE-MRI and DW-MRI is 0.722. The average TPR is 0.998
for the dual pathway network using both DCE-MRI and DW-
MRI as input images. The median FPC is, 5 for the single
pathway network using only DCE-MRI, 6 when using both
MR sequences, and 2 for the dual pathway network. The
single pathway has 111 and 146 false positive objects in total,
using only DCE-MRI and both MR sequences, respectively.
While the dual pathway has 59 false positive objects in total.
Fig. 6 shows the number of detected metastases relative to the
total number of metastases per size category. Both the single
pathway networks fail on the smaller metastases in particular.
Fig. 7 shows the FROC curve of the mean TPR versus the
median FPC for different thresholds T applied to the output of
both networks. The thresholds range from 0.90 to 0.00 with
steps of 0.10. At the highest threshold (T=0.90) only 42%
of the metastases was detected with a median FPC of one
(in total, 31 false positive objects are present) using only the
DCE-MR images, and 65% of the metastases was detected
with a median FPC of one (in total, 25 false positive object
are present) using both MR sequences in the single pathway.
For the dual pathway, 96% of the metastases are detected,
with a median FPC of one (in total, 19 false positive objects
are present). . At the lowest threshold (T=0.0) 84% is de-
tected with only DCE-MR images, 91% is detected with both
Fig. 7. FROC curve of the mean true positive rate and the median number of false
positives per case for threshold T ranging from 0.90 to 0.0 in steps of 0.10. The
circles represent the TPR and FPC at threshold T=0.50.
Fig. 8. Five examples of the lesion detection results. The first row shows results
of the single pathway using only DCE-MRI, the second row the results of the sin-
gle pathway using DCE-MRI and DW-MRI, and the third row shows the results of
the dual pathway network. Green pixels are true positive, red are false negative,
blue are false positive pixels. The orange tissue represents the automatic liver seg-
mentation. The arrows indicate oversegmentation and the arrow head indicates
undersegmentation. From left to right the subjects 2, 4, 5, 10, and 17 are shown.
MR sequences in the single pathway, and all the lesions are
detected with the dual pathway network, but all at the cost of
many false positives.
Fig. 8 shows five examples of the lesion detection results in-
cluding the liver segmentation result. The green pixels are
true positive, blue pixels are false positive, and red pixels are
false negative. Note that true positive objects are connected
components that overlap with a manually annotated metasta-
sis. A true positive object can nonetheless have some under-
segmentation (red pixels, example indicated with arrow head)
or oversegmentation (blue pixels, example indicated with ar-
row).
Discussion
Liver segmentation. Our proposed liver segmentation
method is able to provide high quality liver segmentations us-
ing DCE-MR images. The method is able to deal with com-
mon difficulties in MR segmentation as well as the presence
of lesions.
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The automatic method performs well on the test set of annota-
tion O1.1. The results of the automatic method are similar to
the inter-observer results, as can be seen in the top rows of Ta-
ble 1. Observer 1 annotated the training set so it is not surpris-
ing that the automatic segmentations do well on the test set,
which was annotated by the same observer, in the same anno-
tation session. There is some intra-observer variance between
O1.1 and O1.2 and the second annotations appear systemat-
ically smaller than the first annotations, since the RVD val-
ues involving O1.1 are mostly negative. Still, the automatic
method also performs well when evaluated with annotations
O1.2, as can be seen in the bottom rows of Table 1. Anno-
tations O2 were used to calculate the inter-observer variance,
and were additionally used to evaluate the automatic method
with another observer to verify whether the method general-
izes well. The results using O2 for evaluation are still good,
although slightly worse than the automatic method evaluated
with O1. This is as expected, because the first observer an-
notated the training and validation sets.
The automatic liver segmentation encountered few problems.
However, an outlier in all three metrics was found in one case,
where a large lesion (337 ml) occurred at the edge of the liver.
This outlier has an RVD of -15%, as a result of undersegmen-
tation of the liver in this lesion area. Even though the lesion
is bigger than the receptive field of the neural network, the
method accomplished to recognize half of the lesion tissue
as part of the liver. However, large lesions at the edge of the
liver are a potential pitfall for the proposed liver segmentation
method.
It is hard to compare the liver segmentation results with other
methods, since the data sets and MRI sequences used are not
the same. A rough comparison with recently proposed auto-
matic liver MR segmentation algorithms17,18,25 can be made
by considering the reported values for the DSC. For the men-
tioned studies, the DSC ranged from 0.87 to 0.91, while we
report a DSC of 0.95.
Liver metastases detection. The detection of all liver
metastases is of great importance for adequate treatment.35
The detection method with only DCE-MR images has an av-
erage TPR of 0.645 and a median of 5 false positives per case.
The detection method with the single pathway using both MR
sequences is more effective, with an average TPR of 0.722
and a median of 6 false positives per case. The dual pathway
detection method is able to detect almost all metastases at a
threshold level of 0.50 with a median of 2 false positives per
case. This shows the importance of adding DW-MR images
to the lesion detection method and processing the two MR
sequences in separate pathways. DW-MR images are highly
sensitive for lesions and in combination with the DCE-MR
images the method is able to detect metastases at a high de-
tection rate and a low number of false positives. Fig. 8 shows
some visual examples of the differences in detection of these
three networks.
The usage of the two MR sequences requires the registra-
tion of the DW-MR images to the DCE-MR image space.
Ten registrations failed, which led to the exclusion of these
images from the study. This is likely caused by the free-
breathing protocol used for the DW-MR images that may re-
sult in deformations that cannot be corrected by the registra-
tion method. A more dedicated registration approach or a
breath-hold DW-MR acquisition may improve the robustness
of the method.
One small metastasis is missed by the dual pathway network.
The metastasis is only 5 pixels in size and was detected by the
dual pathway with a probability higher than 0.50. However,
it is deleted during the binary opening in the post-processing
step, where it is seen as noise. This reduction of noisy false
positives comes at the cost of missing very small metastases.
The missed metastases by the single pathway networks are
mostly smaller than 2 cm³, as can be seen in Fig. 6. These
smaller metastases may differ in appearance from larger ones,
because certain features, such as rim enhancement, cannot
be expressed in only a few voxels of the DCE-MR images.
The network with only DCE-MR input images is uncertain
about these metastases, which leads to low outcome proba-
bilities. However, the single pathway with both DCE-MR
and DWI-MR is also less able to detect these smaller metas-
tases. The network seems to fail to create adequate feature
maps to detect small metastases, when it combines the two
MR sequences in the first convolutional layer. The dual path-
way network is allowed to create feature maps for the two
MR sequences separately. The phases of the DCE-MR im-
ages are correlated over time, as are the three b-value images
of the DW-MR. Both MR sequences contain useful charac-
teristics. In the dual pathway network, the feature maps are
solely composed of the MR sequence presented to that path-
way, representing those characteristics. And the feature maps
are combined at the end. This might explain the difference
the detection of the small metastases of the two networks. In
addition, the dual pathway has two times more parameters as
the single pathway. Fig. 8, first column, shows some exam-
ples of sub-centimeter sized metastases.
The dual pathway network detects almost all metastases, but
also incorrectly marks other objects as metastases. Most of
these false positives are caused by objects which are not or
scarcely represented in the training set and have thus an ap-
pearance unknown to the network. These unknown appear-
ances could be other lesions and liver conditions, such as
cirrhosis or an inhomogeneous fat distribution in the liver.
The network has mostly seen healthy liver parenchyma with
metastases during training and has learned to distinguish
these, but is uncertain about conditions and lesions not seen
during training. Fig. 3 (last row) and Fig. 8 (third column)
show examples of cysts marked as a metastasis by the detec-
tion method.
Inspection of the 19 false positive objects for a threshold level
of 0.90 in the post-processing step reveals that 10 of the false
positives are lesions: 9 cysts and 1 hemangioma. Three of the
false positives are blood vessels and one false positive is be-
cause of an inhomogeneous fat distribution in the liver. Fig.
8 (last column) shows an example of a blood vessel marked
as a metastasis. Three other false positives are located on
the edge of the liver, which sometimes has a higher intensity
than the rest of the liver (e.g. Fig. 3 second column). Fur-
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thermore, motion artifacts can be the cause of a false positive
object, which is the case for two false positives.
The morphological operations of on the detection results
were carefully designed for the tasks described. However,
post hoc analysis revealed that the liver mask dilation with a
5×5 structuring element did not seem to be necessary for this
data set, since all liver metastases were included in the origi-
nal liver mask. On the other hand, the morphological closing
and opening of the lesion detection results did have an impact
on the results of the dual pathway method. Without these
morphological operations the median FPC would increase to
8 instead of 2. Nevertheless, the morphological operations
removed one small lesion, from a total of 86, which was oth-
erwise detected.
These CNN models are trained on images from a specific
MR protocol from one clinic. Like other CNN models, there
might be a drop in performance when the model is used on
data from another scanner or another clinic36. To avoid this
problem, the CNN should be fine-tuned on data similar to the
test data, e.g. by using transfer learning.
This work could also be expanded to 3D input images, adding
more spatial information, which might improve the results.
However, this would require more training data and compu-
tational power to train and test a network with more parame-
ters.
Conclusions
An automatic liver segmentation with a similarity index com-
parable to that of the inter-observer agreement, is obtained
from dynamic contrast enhanced MR images with a fully
convolutional neural network. The method can accurately
segment livers irrespective of the liver condition or the pres-
ence of lesions. Only in the event of lesions larger than the
receptive field of the fully convolutional neural network, parts
of the liver are missed.
The proposed dual pathway metastases detection method,
based on dynamic contrast enhanced MR and diffusion
weighted MR images, successfully detects 99.8% of the liver
metastases at the cost of a median of two false positives per
case. This will aid radiologists to locate metastases quickly.
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